Benzinga | Nov 9, 2021 11:05AM EST

Ocular Therapeutix Q3 Sales $12.15M Miss $12.45M Estimate

Ocular Therapeutix (NASDAQ:OCUL) reported quarterly sales of $12.15 million which missed the analyst consensus estimate of $12.45 million by 2.41 percent. This is a 106.77 percent increase over sales of $5.88 million the same period last year.